Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01<sub>E-4</sub> tuberculosis vaccine.
- DOI
- 10.1016/j.vaccine.2026.128690
- Published
- 2026-05-12
- Container
- Vaccine
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2026.128690,
title = {Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01\<sub\>E-4\</sub\> tuberculosis vaccine.},
author = {Dagnew AF and Noble R and Cinar A and Burhan E and Churchyard G and Fairlie L and Hanekom WA and Muyoyeta M and Mwandumba HC and Nduba V and Curran M and Schmidt AC.},
year = {2026},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2026.128690},
url = {https://doi.org/10.1016/j.vaccine.2026.128690}
}RIS
TY - JOUR TI - Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01<sub>E-4</sub> tuberculosis vaccine. AU - Dagnew AF AU - Noble R AU - Cinar A AU - Burhan E AU - Churchyard G AU - Fairlie L AU - Hanekom WA AU - Muyoyeta M AU - Mwandumba HC AU - Nduba V AU - Curran M AU - Schmidt AC. PY - 2026 JO - Vaccine DO - 10.1016/j.vaccine.2026.128690 UR - https://doi.org/10.1016/j.vaccine.2026.128690 ER -
APA
AF, D., R, N., A, C., E, B., G, C., L, F., WA, H., M, M., HC, M., V, N., M, C., & AC., S. (2026). Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01<sub>E-4</sub> tuberculosis vaccine.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128690
Source records
- europe-pmc · retrieved 2026-09-26T15:45:10.529Z